Cell culture media choices that shape biosimilar performance
For biosimilar developers, cell culture performance has two linked dimensions: how efficiently cells produce an antibody and how closely that antibody matches the quality profile of the originator product. Media composition can influence both. Understanding this relationship helps you evaluate supplements according to their contribution to the intended process and product profile. Use product quality […]
Webinar: Improving vaccine production through advanced raw materials for cell-based processes
Webinar details January 29, 2026 The production of cell-based vaccines demands robust, contamination-free upstream processes to ensure product safety, regulatory compliance and manufacturing efficiency. However, identifying high-quality, animal-free raw materials that consistently perform across established cell systems remains a key challenge for vaccine manufacturers. In this webinar, we will present validated solutions using recombinant insulin […]
Webinar: Improving vaccine production through advanced raw materials for cell-based processes
Webinar details January 29, 2026 The production of cell-based vaccines demands robust, contamination-free upstream processes to ensure product safety, regulatory compliance and manufacturing efficiency. However, identifying high-quality, animal-free raw materials that consistently perform across established cell systems remains a key challenge for vaccine manufacturers. In this webinar, we will present validated solutions using recombinant insulin […]
Insulin in stem cell culture
Why optimizing insulin supplementation is crucial Stem cells represent one of the most powerful tools in modern biomedical science. Their unique ability to both self-renew and differentiate into specialized cell types makes them invaluable for research, disease modeling, and the development of regenerative therapies. Realizing this potential, however, requires more than the cells themselves—it depends […]
Biosimilar development process
Biosimilar medicines represent an important advancement in healthcare, offering greater patient access to biological therapies that might otherwise be cost-prohibitive. The biosimilar development process revolves around a comprehensive comparability assessment between the proposed biosimilar and its reference biological product. The primary goal of the development process isn’t to establish the efficacy and safety of the […]
Advancing biologics manufacturing
Optimize biologics manufacturing with Recombinant Insulin—enhancing cell growth, yield, and process consistency for therapeutic production.
Boost cell-based vaccine production with Recombinant Insulin
Boost cell-based vaccine production with Recombinant Insulin. It not only increases viable cell density but also boosts virus and VLP production significantly.
Improve your upstream manufacturing with Recombinant Insulin and TrypsiNNex®
Discover how Recombinant Insulin and TrypsiNNex® can improve your biomanufacturing process. Address contamination risks, ensure consistent quality, and enhance efficiency with animal-free solutions.
Recombinant Insulin HEK293 poster
Monoclonal antibodies | Viral vectors for gene therapy | Cell-based vaccinees | Pluripotent stem cells
Recombinant Insulin HEK293 poster
Monoclonal antibodies | Viral vectors for gene therapy | Cell-based vaccinees | Pluripotent stem cells
